Sweden's Recipharm agrees to buy Britain's Consort Medical for 505 million pounds
Share:
(Reuters) - Swedish pharmaceutical group Recipharm has agreed to buy British peer Consort Medical for 505 million pounds or 6.3 billion crowns ($649 million), the companies said on Monday.They said the owners of Consort Medical, which makes drug delivery devices including nasal inhalers and pharmaceutical compounds, would receive 10.10 pounds per share, valuing the share capital at 505 million pounds on a fully diluted basis. They said in separate statements that the board of Consort Medical..